Antisense oligonucleotides and their technical suitability to nebulization

Leonardo L Seidl1, Regina Moog2, Kirsten A Graeser2

  • 1Roche Pharma Research and Early Development, Therapeutic Modalities, pCMC, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, 4070 Basel, Switzerland; Technical University of Munich, TUM School of Natural Sciences, Boltzmannstr. 10, 85748 Garching, Germany.

Summary

Nebulization of Locked Nucleic Acids (LNAs) is feasible using jet and mesh nebulizers. This study confirms LNA stability, supporting inhalation as a potential delivery route for these biotherapeutics.

Related Concept Videos